The abstract outlines a post hoc analysis assessing the association between mechanical circulatory support center volume and clinical outcomes, but reports no quantitative results.
Observational
Yes
Does mechanical circulatory support center volume affect short- and long-term clinical outcomes in patients with infarct-related cardiogenic shock?
This post hoc analysis of the ECLS-SHOCK trial investigates whether mechanical circulatory support center volume impacts survival in patients with infarct-related cardiogenic shock.
Cardiogenic shock (CS) occurs in up to 10% of patients with acute myocardial infarction (AMI) and remains associated with an excessively high early mortality.1 For haemodynamic stabilization in AMI-CS, the use of extracorporeal life support (ECLS) has significantly increased over the past decade.2 Several factors may influence outcomes of patients receiving ECLS including patient selection and also centre experience.3,4 While some mainly retrospective studies suggest that treatment in high-volume centres does not necessarily lead to lower mortality or may even be associated with higher mortality, other data indicate that a higher CS case volume is linked to improved survival.5–8 Therefore, we conducted a post hoc analysis of the ECLS-SHOCK trial to assess the potential associations between mechanical circulatory support (MCS) centre volume and both short- and long-term clinical outcomes. The trial design, including eligibility criteria, informed consent process, data collection, 30-day, and 1-year outcomes has been published previously.3,9
Abumayyaleh et al. (Sun,) conducted a observational in Infarct-related cardiogenic shock. Mechanical circulatory support center volume was evaluated on Short- and long-term clinical outcomes. The abstract outlines a post hoc analysis assessing the association between mechanical circulatory support center volume and clinical outcomes, but reports no quantitative results.